Lucozade, Ribena sale

British pharmaceuticals company GlaxoSmithKline is to sell brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).

British pharmaceuticals company GlaxoSmithKline is to sell brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).

Related Articles